Implementation and clinical evaluation of an Mpox virus laboratory-developed test on a fully automated random-access platform.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
08 2023
Historique:
revised: 06 07 2023
received: 20 03 2023
accepted: 25 07 2023
medline: 14 8 2023
pubmed: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

While Mpox virus (MPXV) diagnostics were performed in specialized laboratories only, the global emergence of Mpox cases in 2022 revealed the need for a more readily available diagnostic. Automated random-access platforms with fast nucleic acid extraction and PCR have become established in many laboratories, providing faster and more accessible testing. In this study, we adapted a previously published generic MPXV-PCR as a lab-developed test (LDT) on a NeuMoDx Molecular System and isolated MPXV clones from patient materials. To reduce the handling of infectious material, we evaluated a viral lysis buffer (VLB) for sample pretreatment. We further compared the MPXV-LDT-PCR to conventional real-time PCR, determined its sensitivity and specificity using positive swabs, and assessed its performance using external quality assessment samples. Pretreatment of samples with 50% VLB reduced MPXV infectivity by approximately 200-fold while maintaining PCR sensitivity. The assay demonstrated a sensitivity and specificity of 100% with no cross-reactivity in the samples tested and performed with a limit of detection of 262 GE/mL. In summary, the assay had a turnaround time of fewer than 2 h and can easily be transferred to other automated PCR platforms, providing a basis for developing rapid assays for upcoming pandemics.

Identifiants

pubmed: 37565757
doi: 10.1002/jmv.29022
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29022

Informations de copyright

© 2023 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.

Références

Jones KE, Patel NG, Levy MA, et al. Global trends in emerging infectious diseases. Nature. 2008;451(7181):990-993.
Antràs P, Redding SJ, Rossi-Hansberg E. Globalization and Pandemics. National Bureau of Economic Research; 2020.
Mostafa HH, Lamson DM, Uhteg K, et al. Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 test. J Clin Virol. 2020;130:104583.
Perchetti GA, Pepper G, Shrestha L, et al. Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay. J Clin Virol. 2021;140:104869.
Paradis S, Lockamy E, Cooper CK, Young S. Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system. J Clin Virol. 2021;143:104946.
Broder K, Babiker A, Myers C, et al. Test agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 assays at high cycle threshold ranges. J Clin Microbiol. 2020;58(8):e01187-20.
World Health Organization. WHO coronavirus (COVID-19) dashboard. 2022. Accessed June 19, 2023. https://covid19.who.int/
Centers for Disease Control and Prevention. Monkeypox outbreak global map. 2022. Accessed June 19, 2023. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci. 2023;120(8):e2220415120.
Li Y, Zhao H, Wilkins K, Hughes C, Damon IK. Real-time PCR assays for the specific detection of monkeypox virus West African and Congo Basin strain DNA. J Virol Methods. 2010;169(1):223-227.
Ramakrishnan MA. Determination of 50% endpoint titer using a simple formula. World journal of virology. 2016;5(2):85.
Papadakis G, Tran T, Druce J, Lim CK, Williamson DA, Jackson K. Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses. J Clin Virol. 2023;161:105424.
Mills MG, Juergens KB, Gov JP, et al. Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays. J Clin Virol. 2023;159:105373.
Huggett JF, French D, O'Sullivan DM, Moran-Gilad J, Zumla A. Monkeypox: another test for PCR. Euro Surveill. 2022;27(32):2200497.
Wu, F, Oghuan J, Gitter A, Mena KD, Brown EL. Wide mismatches in the sequences of primers and probes for monkeypox virus diagnostic assays. J Med Virol. 2023;95(1):e28395.

Auteurs

Jochen M Wettengel (JM)

School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Helmholtz Munich, School of Medicine, Institute of Virology, Munich, Germany.
German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.

Till Bunse (T)

School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Helmholtz Munich, School of Medicine, Institute of Virology, Munich, Germany.
German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.

Samuel D Jeske (SD)

School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.

Roman Wölfel (R)

German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.
Bundeswehr, Institute of Microbiology, Munich, Germany.

Sabine Zange (S)

German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.
Bundeswehr, Institute of Microbiology, Munich, Germany.

Julia Taeubner (J)

QIAGEN GmbH, Strategic Lab Consultancy, Hilden, Germany.

Uta Goelnitz (U)

QIAGEN GmbH, Strategic Lab Consultancy, Hilden, Germany.

Ulrike Protzer (U)

School of Medicine, Institute of Virology, Technical University of Munich, Munich, Germany.
Helmholtz Munich, School of Medicine, Institute of Virology, Munich, Germany.
German Center for Infection Research (DZIF), Munich Partner Site, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH